Skip to main content
. 2019 Nov 30;20(23):6056. doi: 10.3390/ijms20236056

Figure 1.

Figure 1

(A) Nanoparticle publications in PubMed as of 1 October 2019. (B) Nanoparticles currently in clinical trials (clinicaltrials.gov). There are currently no phase III clinical trials for drug delivery nanoparticles. Surface Modified (SM), Drug Delivery Nanoparticles (DDN), Active trails (A), Withdrawn/Terminated (W/T), Completed (C), Unknown Status (US). Note that SM is a subset of DDN.